Validation of the Turkish Translation of the Low Anterior Resection Syndrome (LARS) Score
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 222
- 主要终点
- Validity of LARS Score
研究概览
简要总结
Long-term bowel dysfunction after resection for rectal cancer, known as low anterior resection syndrome (LARS), is observed in many patients. The LARS score was developed to measure this syndrome and its impact on quality of life in Danish patients. Recently, English and many other language versions have been validated. The aim of this study was to validate the Turkish translation of the LARS score in Turkish patients who have undergone treatment for rectal cancer.
详细描述
A total of 326 patients were reviewed and contacted for the study, and 222 (68%) were eligible for the analyses. The association between the LARS score and quality of life and the test-retest reliability were studied. The intraclass correlation coefficient (ICC) was calculated to understand the degree of reliability.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The inclusion criteria were
- •rectal adenocarcinoma within 15 cm from the anal verge
- •LAR with either PME or TME.
- •Bowel continuity restored for at least 18 months when invited for the study.
排除标准
- •Exclusion criteria included
- •failed R0 surgery,
- •recurrence or dissemination,
- •having intestinal stoma,
- •previous cancer (except minor skin cancers)
- •dementia and inability to speak Turkish (i.e., the need for a translator during treatment).
结局指标
主要结局
Validity of LARS Score
时间窗: From Feb 2016 to Feb 2020
The translated questionaire was validated on Turkish speaking patients
次要结局
未报告次要终点
研究者
I Ethem Gecim
Professor of Surgery
Ankara University